{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:13:10Z","timestamp":1771510390812,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019257","name":"Key Laboratory of Myocardial Ischemia, Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["KF201807"],"award-info":[{"award-number":["KF201807"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1301100"],"award-info":[{"award-number":["2016YFC1301100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.atherosclerosis.2020.04.008","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:28:49Z","timestamp":1587554929000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction"],"prefix":"10.1016","volume":"302","author":[{"given":"Weili","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sining","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib1","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/CIRCRESAHA.114.302782","article-title":"Global perspective on acute coronary syndrome: a burden on the young and poor","volume":"114","author":"Vedanthan","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib2","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehv029","article-title":"Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome","volume":"36","author":"Niccoli","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005860","article-title":"EROSION study (effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion): a 1-year follow-up report","volume":"10","author":"Xing","year":"2017","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib5","first-page":"792","article-title":"Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study)","volume":"38","author":"Jia","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1194\/jlr.S092874","article-title":"Advances in determining signaling mechanisms of ceramide and role in disease","volume":"60","author":"Stith","year":"2019","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.116.305675","article-title":"Sphingolipids contribute to human atherosclerotic plaque inflammation","volume":"36","author":"Edsfeldt","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/hh2301.100350","article-title":"Sphingolipid mediators in cardiovascular cell biology and pathology","volume":"89","author":"Levade","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/ATVBAHA.118.311208","article-title":"nSMase2 (type 2-neutral sphingomyelinase) deficiency or inhibition by GW4869 reduces inflammation and atherosclerosis in apoe(-\/-) mice","volume":"38","author":"Lallemand","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2008.06.005","article-title":"Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice","volume":"58","author":"Park","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib11","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/CIRCULATIONAHA.116.024261","article-title":"Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevencion con Dieta Mediterranea)","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib12","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.atherosclerosis.2015.10.022","article-title":"Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: results of the ATHEROREMO-IVUS study","volume":"243","author":"Cheng","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib15","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jacc.2013.05.071","article-title":"In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography","volume":"62","author":"Jia","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib16","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","volume":"38","author":"Meeusen","year":"2018","journal-title":"Plasma Ceramides Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib17","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1021\/ac500317c","article-title":"Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid chromatography-mass spectrometry","volume":"86","author":"Sarafian","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.atherosclerosis.2007.09.018","article-title":"Ceramide: a common pathway for atherosclerosis?","volume":"196","author":"Bismuth","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.115.303881","article-title":"Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation","volume":"115","author":"Freed","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib20","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1172\/JCI118934","article-title":"Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins","volume":"98","author":"Schissel","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2796.2008.01947.x","article-title":"From vulnerable plaque to atherothrombosis","volume":"263","author":"Thim","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.pmbts.2017.01.004","article-title":"Evidence for the involvement of matrix-degrading metalloproteinases (MMPs) in atherosclerosis","volume":"147","author":"Brown","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib24","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/01.CIR.0000035650.05921.50","article-title":"Dual effect of ceramide on human endothelial cells","volume":"106","author":"Li","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib25","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/eurheartj\/ehy101","article-title":"In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study","volume":"39","author":"Dai","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib26","first-page":"1","article-title":"Plasma ceramide species are associated with diabetes risk in participants of the strong heart study","author":"Fretts","year":"2019","journal-title":"J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molmet.2018.12.008","article-title":"The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach","volume":"21","author":"Raichur","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib28","doi-asserted-by":"crossref","first-page":"E2335","DOI":"10.1210\/jc.2014-1665","article-title":"Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome","volume":"99","author":"Ng","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib29","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1210\/jc.2013-2559","article-title":"Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency","volume":"99","author":"Tarasov","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib30","first-page":"381","article-title":"Coronary artery disease: ceramides predict CV death in stable CAD and ACS","volume":"13","author":"Huynh","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.04.008_bib31","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1253\/circj.CJ-17-0363","article-title":"Detection of ceramide, a risk factor for coronary artery disease, in human coronary plaques by fluorescent angioscopy","volume":"81","author":"Uchida","year":"2017","journal-title":"Circ. J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020302033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020302033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:41:39Z","timestamp":1758156099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915020302033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":31,"alternative-id":["S0021915020302033"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.04.008","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}